Gilder Gagnon Howe & Co’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
|
|||||
2024
Q2 | $49.8M | Sell |
|
|||||
2024
Q1 | $65.4M | Sell |
|
|||||
2023
Q4 | $59.8M | Sell |
|
|||||
2023
Q3 | $46.8M | Sell |
|
|||||
2023
Q2 | $72.9M | Sell |
|
|||||
2023
Q1 | $70.4M | Sell |
|
|||||
2022
Q4 | $72.1M | Sell |
|
|||||
2022
Q3 | $51.4M | Sell |
|
|||||
2022
Q2 | $53M | Sell |
|
|||||
2022
Q1 | $106M | Sell |
|
|||||
2021
Q4 | $112M | Sell |
|
|||||
2021
Q3 | $116M | Sell |
|
|||||
2021
Q2 | $92.2M | Sell |
|
|||||
2021
Q1 | $84.9M | Sell |
|
|||||
2020
Q4 | $94.6M | Sell |
|
|||||
2020
Q3 | $186M | Sell |
|
|||||
2020
Q2 | $204M | Sell |
|
|||||
2020
Q1 | $159M | Sell |
|
|||||
2019
Q4 | $141M | Sell |
|
|||||
2019
Q3 | $99.3M | Sell |
|
|||||
2019
Q2 | $113M | Buy |
|
|||||
2019
Q1 | $81M | Sell |
|
|||||
2018
Q4 | $88.4M | Buy |
|
|||||
2018
Q3 | $100M | Buy |
|
|||||
2018
Q2 | $56.7M | Buy |
|
|||||
2018
Q1 | $43.5M | Buy |
|
|||||
2017
Q4 | $7.68M | Buy |
|
|||||
2017
Q3 | – | Sell |
|
|||||
2017
Q2 | $3.18M | Sell |
|
|||||
2017
Q1 | $38.4M | Sell |
|
|||||
2016
Q4 | $31.3M | Sell |
|
|||||
2016
Q3 | $61.2M | Sell |
|
|||||
2016
Q2 | $62.4M | Sell |
|
|||||
2016
Q1 | $54.8M | Sell |
|
|||||
2015
Q4 | $72.7M | Sell |
|
|||||
2015
Q3 | $76.6M | Sell |
|
|||||
2015
Q2 | $77.4M | Sell |
|
|||||
2015
Q1 | $76.1M | Sell |
|
|||||
2014
Q4 | $103M | Sell |
|
|||||
2014
Q3 | $157M | Sell |
|
|||||
2014
Q2 | $156M | Sell |
|
|||||
2014
Q1 | $164M | Sell |
|
|||||
2013
Q4 | $143M | Sell |
|
|||||
2013
Q3 | $115M | Buy |
|
|||||
2013
Q2 | $84.1M | Buy |
|